fincash logo SOLUTIONS

Fincash » Search » Ipca Laboratories Ltd

Ipca Laboratories Ltd

Updated on March 19, 2019

Stock/Share Code - IPCALAB

Ipca Laboratories is a integrated pharmaceutical company manufacturing and marketing over 350 formulations and 80 APIs covering various therapeutic segments.

Below is the details of IPCALAB Ipca Laboratories Ltd

Market Cap₹10,232 Cr.
Current Price ₹916.85 as on 25 Mar 19
52 Week High / Low Price₹828 / ₹590.1
Face Value₹2
Stock P/E25.79
Book Value₹227.39
Dividend Yield0.12 %
ROCE9.33 %
ROE8.83 %
Sales Growth (3yrs)1.13 %
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Cons: Stock is trading at 3.56 times its book value The company has delivered a poor growth of 2.82% over past five years. Tax rate seems low Company has a low return on equity of 6.96% for last 3 years. Company might be capitalizing the interest cost Dividend payout has been low at 4.04% of profits over last 3 years

Ipca Laboratories Ltd Price Chart

Ipca Laboratories Ltd Price Chart

Ipca Laboratories Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Piramal Enterp. ₹2,573.5 8.18 ₹42,817.87 Cr. 1.05 ₹603.98 Cr. 23.03 22.07 3489.08 8.85
2. Sun Pharma.Inds. ₹188.05 22.89 ₹106,806.4 Cr. 0.45 ₹1,461.03 Cr. 310.00 16.34 7740.19 10.41
3. Aurobindo Pharma ₹775.85 17.77 ₹41,719.55 Cr. 0.35 ₹712.22 Cr. 22.97 21.53 5269.67 22.85
4. Cadila Health. ₹332.1 16.48 ₹32,626.67 Cr. 1.10 ₹510.7 Cr. -6.00 9.75 3577.90 18.28
5. Dr Reddy's Labs ₹2,780.95 24.73 ₹43,701.41 Cr. 0.76 ₹500.3 Cr. 65.28 0.80 3864.60 7.75
6. Cipla ₹526.85 32.21 ₹44,680.04 Cr. 0.54 ₹332.2 Cr. -17.06 2.39 4007.54 9.64
7. Strides Pharma ₹436.7 4.39 ₹3,769.14 Cr. 0.47 ₹293.42 Cr. 234.73 6.10 794.50 16.15
8. Ipca Labs. ₹373.9 25.79 ₹10,232 Cr. 0.12 ₹160.18 Cr. 51.71 10.24 947.59 9.33

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ipca Laboratories Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018
YOY Sales Growth %-0.39%13.04%18.42%9.38%6.49%-16.53%-2.23%14.58%16.84%19.7%15.4%10.24%
Material Cost %34.66%36.65%36.14%32.35%34.66%37.51%34.12%34.19%32.75%32.52%31.4%31.63%
Employee Cost %23.76%20.96%19.9%21.47%23.73%24.48%21.65%21.21%21.57%22.88%20.42%18.6%
Operating Profit551201351067122149162109114173232
OPM %9%14%15%14%11%3%17%19%14%13%17%24%
Other Income1256646111113141413
Profit before tax1677926426-211101237278141197
Tax %-110%38%40%35%-73%5%12%14%28%16%15%19%
Net Profit3348554144-20961065166120160

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018TTM
Sales Growth %22.6%13.4%20.83%22.26%18.97%23.83%19.28%16.43%-4.54%-9.2%10.65%2.94%%
Material Cost %43.5%45.08%40.38%42.35%40.8%38.95%39.27%34.85%37.02%37.33%35.7%34.84%%
Manufacturing Cost %7.19%7.27%7.09%6.17%6.63%7.35%10.45%7.94%9.53%9.83%9.24%9.4%%
Employee Cost %10.89%13.08%13.82%13.11%13.91%13.83%13.55%14.77%17.53%21.52%21.76%22.32%%
Other Cost %19.74%19.61%25.91%18.84%16.19%19.93%16.55%19.68%18.71%21.47%19.29%19.51%%
Operating Profit176160166309423464561736531276435445627
OPM %19%15%13%20%22%20%20%23%17%10%14%14%18%
Other Income24732441-21219213328214053
Profit before tax151177114272334369461629358111258283488
Tax %19%20%20%23%23%24%28%24%28%17%27%18%
Net Profit1221419120925528033147725693188233397
EPS in Rs9.5410.986.9316.2419.7921.7425.6037.8320.297.3314.9218.47
Dividend Payout %15%14%30%17%16%14%15%13%5%0%7%5%

Compounded Sales Growth

  • 10 Years:: 11.55%
  • 5 Years:: 2.82%
  • 3 Years:: 1.13%
  • TTM:: 15.27%

Compounded Profit Growth

  • 10 Years:: 4.86%
  • 5 Years:: -6.99%
  • 3 Years:: -3.24%
  • TTM:: 75.41%

Return on Equity

  • 10 Years:: 15.03%
  • 5 Years:: 11.07%
  • 3 Years:: 6.96%
  • TTM:: 8.83%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Sep 2018
Share Capital25252525252525252525252525
Equity Capital2525.0924.9925.0425.1425.1725.2425.2425.2425.2425.2425.24
Other Liabilities263216282297334472528648671812835861957
Trade Payables65.4266.6965.4669.31184.17258.05218.82295.32344.01444.5371.39385.73452.85
Total Liabilities9881,1771,3701,6261,9182,3352,7153,2243,8333,9604,0264,1834,298
Fixed Assets3744135636366989131,0751,3061,7531,9771,9461,8551,821
Gross Block509.23577.09763.99878.47985.581284.511524.851851.292465.92137.322276.992358.72
Accumulated Depreciation132.19164.38200.96242287.76371.69449.52545.18712.94160.74331.02504.11
Other Assets5316047349021,0771,2851,4881,7241,7321,7571,7732,0402,402
Trade receivables180.98263.76342.77391.91369.87345.11415.93448.76353.55441.45501.98594.38768.17
Cash Equivalents5.577.595.848.298.449.2554.6669.22113.19161.9817.53131.03134.03
Loans n Advances112.6173.3385.23130.52196.1182.91186.62232.93218.91220.06262.93314.67118.12
Total Assets9881,1771,3701,6261,9182,3352,7153,2243,8333,9604,0264,1834,298

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
Cash from Operating Activity113110155194215222387515455696271324
Profit from operations187.82186.44268.57337.49380.76519.08578.6763.45539.76312.72420.02463.45
Working Capital Changes-50.68-46.05-90.06-97.55-102.16-216.85-100.02-118.48-9.96412.34-94.56-82.18
Taxes paid-24.73-30.08-23.59-46.42-64.03-79.9-91.73-130.19-74.46-29.06-54.32-57.41
Cash from Investing Activity-91-145-106-127-199-228-261-362-686-214-146-119
Fixed Assets Purchased-89.11-143.7-78.75-143.44-194.62-239.38-228.55-371.14-554.87-241.76-134.53-72.32
Fixed Assets Sold1.230.890.631.011.260.951.180.811.561.671.02
Investments purchased-504.28-574.97-481.68-481.95-618.27-1315.61-1805.99-1903.12-2037.90-2100-2456.04
Investments sold499.19570.48455.32491.1610.411315.611832.391906.22046.14.192107.372472.86
Cash from Financing Activity-2137-51-64-176-81-138255-414-156-130
Proceeds from Shares01.772.312.562.190.760.3100000
Proceeds from Borrowings32.0788.8215.0271.2195.63137.23110.3966.9487.75151.8367.794.15
Repayment of Borrowings-12.97-14.79-48.16-69.05-41.54-81.47-96.92-110.85-109.63-517.2-196.01-181.79
Interest Paid-21.13-16.86-29.37-28.78-29.22-36.7-34.3-28.29-31.28-28.45-22.84-22.48
Dividends Paid-18.54-21.94-33.62-37.87-43.86-46.66-46.78-66.12-36.85-15.34-0.24-15.33
Net Cash Flow22-22-1145142568-3174

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.


Mar 2007Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018
ROCE %27%24%16%25%26%24%24%27%13%4%9%9%
Debtor Days709097907254555142575968
Inventory Turnover4.544.354.624.724.514.143.984.123.523.213.643.66

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Ipca Laboratories Ltd & Get More Returns than Bank Deposit

All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.